AAAAAA

   
Results: 1-15 |
Results: 15
Combination gene therapy with adenoviral vector-mediated HSV-tk plus GCV and IL-12 in an orthotopic mouse model for prostate cancer
Authors: Nasu, Y Bangma, CH Hull, GW Yang, G Wang, J Shimura, S McCurdy, MA Ebara, S Lee, HM Timme, TL Thompson, TC
Citation: Y. Nasu et al., Combination gene therapy with adenoviral vector-mediated HSV-tk plus GCV and IL-12 in an orthotopic mouse model for prostate cancer, PROSTATE C, 4(1), 2001, pp. 44-55
Prostate-specific antigen response and systemic T cell activation after insitu gene therapy in prostate cancer patients failing radiotherapy
Authors: Miles, BJ Shalev, M Aguilar-Cordova, E Timme, TL Lee, HM Yang, G Adler, HL Kernen, K Pramudji, CK Satoh, T Gdor, Y Ren, CZ Ayala, G Wheeler, TM Butler, EB Kadmon, D Thompson, TC
Citation: Bj. Miles et al., Prostate-specific antigen response and systemic T cell activation after insitu gene therapy in prostate cancer patients failing radiotherapy, HUM GENE TH, 12(16), 2001, pp. 1955-1967
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression
Authors: Shaker, MR Yang, G Timme, TL Park, SH Kadmon, D Ren, CZ Ji, XR Lee, HM Sehgal, I Anzano, M Sporn, MB Thompson, TC
Citation: Mr. Shaker et al., Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression, CLIN EXP M, 18(5), 2001, pp. 429-438
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells
Authors: Li, LK Yang, G Ebara, S Satoh, T Nasu, Y Timme, TL Ren, CZ Wang, JX Tahir, SA Thompson, TC
Citation: Lk. Li et al., Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells, CANCER RES, 61(11), 2001, pp. 4386-4392
Secreted caveolin-1 stimulates cell survival/clonal growth and contributesto metastasis in androgen-insensitive prostate cancer
Authors: Tahir, SA Yang, G Ebara, S Timme, TL Satoh, T Li, LK Goltsov, A Ittmann, M Morrisett, JD Thompson, TC
Citation: Sa. Tahir et al., Secreted caveolin-1 stimulates cell survival/clonal growth and contributesto metastasis in androgen-insensitive prostate cancer, CANCER RES, 61(10), 2001, pp. 3882-3885
Molecular pathways underlying prostate cancer progression - The role of caveolin-1
Authors: Thompson, TC Timme, TL Li, LK Ren, CZ Goltsov, A Tahir, S Yang, G
Citation: Tc. Thompson et al., Molecular pathways underlying prostate cancer progression - The role of caveolin-1, CONT CANC R, 2001, pp. 267-277
Prostate cancer gene therapy: Comparison of adenovirus-mediated expressionof interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines
Authors: Hull, GW McCurdy, MA Nasu, Y Bangma, CH Yuang, G Shimura, S Lee, HM Wang, JX Albani, J Ebara, S Sato, T Timme, TL Thompson, TC
Citation: Gw. Hull et al., Prostate cancer gene therapy: Comparison of adenovirus-mediated expressionof interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines, CLIN CANC R, 6(10), 2000, pp. 4101-4109
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis
Authors: Timme, TL Goltsov, A Tahir, S Li, LK Wang, JX Ren, CZ Johnston, RN Thompson, TC
Citation: Tl. Timme et al., Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis, ONCOGENE, 19(29), 2000, pp. 3256-3265
Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease
Authors: Thompson, TC Timme, TL Park, SH Yang, G Ren, CZ
Citation: Tc. Thompson et al., Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease, PROSTATE, 43(4), 2000, pp. 248-254
Resistance to lysis by cytotoxic T cells: A dominant effect in metastatic mouse prostate cancer cells
Authors: Lee, HM Timme, TL Thompson, TC
Citation: Hm. Lee et al., Resistance to lysis by cytotoxic T cells: A dominant effect in metastatic mouse prostate cancer cells, CANCER RES, 60(7), 2000, pp. 1927-1933
Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer
Authors: Thompson, TC Timme, TL Li, L Goltsov, A
Citation: Tc. Thompson et al., Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer, APOPTOSIS, 4(4), 1999, pp. 233-237
In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial
Authors: Herman, JR Adler, HL Aguilar-Cordova, E Rojas-Martinez, A Woo, S Timme, TL Wheeler, TM Thompson, TC Scardino, PT
Citation: Jr. Herman et al., In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial, HUM GENE TH, 10(7), 1999, pp. 1239-1249
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in anorthotopic model
Authors: Nasu, Y Bangma, CH Hull, GW Lee, HM Wang, J McCurdy, MA Shimura, S Yang, G Timme, TL Thompson, TC
Citation: Y. Nasu et al., Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in anorthotopic model, GENE THER, 6(3), 1999, pp. 338-349
Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer
Authors: Hall, SJ Mutchnik, SE Yang, G Timme, TL Nasu, Y Bangma, CH Woo, SLC Shaker, M Thompson, TC
Citation: Sj. Hall et al., Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer, CANC GENE T, 6(1), 1999, pp. 54-63
Elevated levels of circulating interleukin-6 and transforming growth factor-beta 1 in patients with metastatic prostatic carcinoma
Authors: Adler, HL McCurdy, MA Kattan, MW Timme, TL Scardino, PT Thompson, TC
Citation: Hl. Adler et al., Elevated levels of circulating interleukin-6 and transforming growth factor-beta 1 in patients with metastatic prostatic carcinoma, J UROL, 161(1), 1999, pp. 182-187
Risultati: 1-15 |